Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

Share Price Information for Versarien (VRS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.105
Bid: 0.10
Ask: 0.105
Change: -0.002 (-1.91%)
Spread: 0.005 (5.00%)
Open: 0.1005
High: 0.105
Low: 0.1005
Prev. Close: 0.1045
VRS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Debt for Equity Swap with UoM

31 Oct 2016 09:15

RNS Number : 8503N
Versarien PLC
31 October 2016
 

31 October 2016

Versarien plc("Versarien" or the "Company")

Debt for Equity Swap with UoM

Issue of Equity

 

Versarien Plc (AIM: VRS), the advanced materials engineering group is pleased to confirm that following discussions with the University of Manchester ("UoM") the Company and its subsidiary 2-DTech Limited will convert amounts due to UoM in respect of certain graphene collaboration agreements and proof of principle loans totalling £191,465 into equity of the Company. The proposed conversion of this debt will be at a price of 19.14 pence per share, and will result in the issue of 1,000,389 new ordinary shares representing 0.83 per cent. of the enlarged issued share capital.

 

UoM owns 15 per cent. of the shares of 2-DTech following Versarien's majority acquisition of 2-DTech in April 2014.

 

This announcement includes inside information as defined in Article 7 of the Market Abuse Regulation No. 596/2014 and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.

 

The debt for equity swap will be transacted at a price of 19.14 pence per share, a premium of 76 per cent. compared with the mid-market price of 10.875 pence per share at which the Ordinary Shares were quoted on AIM as at close of trading on 28 October 2016, the last trading day prior to announcement of the debt for equity swap.

 

Neill Ricketts, Chief Executive Officer commented on the agreement: "This deal further strengthens the relationship between the Company and UoM, the home of graphene, and we are delighted that UoM has further demonstrated its confidence in the progress Versarien is making in commercialising the graphene technology since its sale of 85% of the business to Versarien in 2014 by its willingness to accept shares at a substantial premium over the current market price."

 

Clive Rowland, CEO of the University's innovation company, UMI3, said: "As graphene applications are coming ever closer to becoming products in the market-place we continue to see our relationship with 2-DTech as being an important part of our network which forms our bridge between the 2D materials work taking place on campus and potential customers for graphene in a range of industry sectors."

 

Application for admission to trading on AIM of the 1,000,389 new Ordinary Shares being issued pursuant to the placing has been made and admission is expected to take place on 4 November 2016. The New Ordinary Shares will rank pari passu with the existing Ordinary Shares in issue.

 

In accordance with the provisions of the Disclosure Guidance and Transparency Rules of the FCA, the Company confirms that, following the Placing, its issued share capital will comprise 119,844,003 Ordinary Shares of 1 pence each. All Ordinary Shares shall have equal voting rights and none of the Ordinary Shares are held in treasury. The total number of voting rights in the Company immediately following Admission will therefore be 119,844,003.

 

 

For further information please contact:

 

Versarien plc

www.versarien.com

Neill Ricketts - Chief Executive Officer

+44 (0) 1594 888 622

Chris Leigh - Chief Financial Officer

WHIreland (Nominated Adviser and Broker)

www.whirelandplc.com

Mike Coe / Ed Allsopp

+44 (0) 117 945 3470

IFC Advisory (Financial PR and IR)

www.investor-focus.co.uk

Tim Metcalfe / Graham Herring /

Heather Armstrong/Miles Nolan

+44 (0) 20 3053 8671

 

Notes to Editors:

About Versarien

Versarien plc (AIM:VRS), is an advanced materials group. Leveraging proprietary technology, the Group creates innovative engineering solutions for its clients in a diverse range of industries. Versarien has three subsidiaries:

Versarien Technologies Ltd owns the exclusive rights to a patent-protected additive process for creating advanced micro-porous metals targeting the thermal management industry and manufactures extruded aluminium heat sinks for the electronics and computing industries. www.versarien-technologies.co.uk

Versarien Advanced Composites Limited has been established in order to progress the commercial application of graphene-enhanced composite products.

Total Carbide Ltd, a leading manufacturer in sintered tungsten carbide for applications in arduous environments such as the oil and gas industry. www.totalcarbide.com

2-DTech Ltd., which specialises in the supply, characterisation and early stage development of graphene products. www.2-dtech.com

ACC Cyroma was established in 2002 and operates from a 45,000 square foot facility in Banbury, Oxfordshire. Using Versarien's existing graphene manufacturing capabilities, in combination with AAC Cyroma's knowledge, plant and equipment, the acquisition will provide the Group with an ability to produce graphene enhanced products for an established customer base, both domestic and international, including leading automotive OEMs. Versarien believes this will be the first dedicated graphene enhanced plastics manufacturing factory in the world.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCAKDDDCBDKKKN
Date   Source Headline
30th Apr 202411:59 amRNSResult of AGM
28th Mar 20247:00 amRNSAudited Results for year ended 30 September 2023
28th Mar 20247:00 amRNSTotal Voting Rights
20th Mar 20248:33 amRNSPlacing to raise £615,000
14th Mar 20247:00 amRNSSouth American Graphinks Agreements
11th Mar 20247:00 amRNSSale of Korean Assets and Licencing of IP
16th Feb 20242:22 pmRNSNotification of final results
7th Feb 20247:00 amRNSReceipt of Legal Claims
31st Jan 20247:00 amRNSTotal Voting Rights
23rd Jan 20244:53 pmRNSHolding(s) in Company
23rd Jan 20241:24 pmRNSHolding(s) in Company
19th Jan 20247:00 amRNSPlacing to raise £400,000
10th Jan 202411:29 amRNSResult of General Meeting
20th Dec 20237:00 amRNSCompany Update and Notice of General Meeting
30th Nov 20237:00 amRNSTotal Voting Rights
8th Nov 20237:00 amRNSPlacing to raise £454,822
30th Oct 202311:52 amRNSResult of General Meeting
30th Oct 20237:00 amRNSGeneral Meeting Statement
12th Oct 20237:00 amRNSNotice of General Meeting
2nd Oct 20237:00 amRNSCorporate Update
13th Sep 20237:00 amRNSTurnaround Strategy - Gnanomat Grant Award
31st Jul 20237:00 amRNSTotal Voting Rights
18th Jul 20234:31 pmRNSDirectorate Changes
14th Jul 20237:00 amRNSPlacing to raise £650,000
4th Jul 202310:54 amRNSResult of General Meeting
4th Jul 20237:00 amRNSGeneral Meeting Statement
15th Jun 20237:00 amRNSNotice of General Meeting
9th Jun 20237:00 amRNSInterim Results
31st May 20237:00 amRNSTotal Voting Rights
17th May 20237:00 amRNSSuccessful Cementene precast concrete trials
3rd May 20239:30 amRNSPlacing and Update on Turnaround Strategy
31st Mar 20237:00 amRNSTotal Voting Rights
29th Mar 202311:22 amRNSResult of AGM
29th Mar 20237:00 amRNSAGM Statement
15th Mar 20237:00 amRNSPlacing to raise £318,000
14th Mar 20232:56 pmRNSFurther re Resignation of Chief Executive Officer
10th Mar 20237:00 amRNSResignation of Chief Executive Officer
6th Mar 20237:00 amRNSCostain Civil Engineering Project
1st Mar 202312:00 pmRNSUmbro Launch
28th Feb 20237:00 amRNSNotice of AGM and Posting of Annual Report
21st Feb 20237:00 amRNSResults for the 18 months ended 30 September 2022
9th Feb 20238:33 amRNSAIM Rule 17 Update
27th Jan 20237:00 amRNSGraphene-Wear OEKO-TEX Eco Passport certification
24th Jan 20231:56 pmRNSFinal Results Update
30th Dec 20227:00 amRNSTotal Voting Rights
6th Dec 20229:40 amRNSPlacing to raise £1.85 million
5th Dec 20224:40 pmRNSSecond Price Monitoring Extn
5th Dec 20224:35 pmRNSPrice Monitoring Extension
5th Dec 20227:00 amRNSG-SCALE Update & Innovate UK Loan Variation
2nd Dec 20224:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.